Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses-Reference-Cited by-同舟云学术

Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses

Published:2016-03-07 Issue:9 Volume:56 Page:1120-1129
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Kjeldsen Sverre E.¹,Cha Gloria²,Villa Giuseppe³,Mancia Giuseppe⁴,

Affiliation:

1. Oslo University Hospital Ullevaal University of Oslo Oslo Norway

2. KRK Medical Research Institute Dallas Texas USA

3. Fondazione S. Maugeri—IRCCS Pavia Italy

4. University of Milano‐Bicocca IRCCS Istituto Auxologico Italiano Milan Italy

Funder

Bayer Pharmaceutical Division

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.712

Reference37 articles.

1. Ambulatory Blood Pressure Monitoring in the Evaluation of Antihypertensive Treatment: Additional Information from a Large Data Base

2. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

3. A Review of the Antihypertensive Effects of Felodipine Alone or in Combination

4. Treatment and Control of Hypertension in the Community

5. Original Papers

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and Tolerability of Nifedipine GITS in Patients with Chronic Kidney Disease and Uncontrolled Hypertension: A Prospective, Multicenter, Observational Study (ADRENAL);Advances in Therapy;2021-07-30

2. Impact of baseline blood pressure on the magnitude of blood pressure lowering by nifedipine gastrointestinal therapeutic system: refreshing the Wilder’s principle;Drug Design, Development and Therapy;2017-11

3. Pharmacokinetics and safety of nifedipine GITS/candesartan fixed-dose combination in subjects with hepatic impairment;Int. Journal of Clinical Pharmacology and Therapeutics;2017-03-01